history of glp-1 medications glucagon-like peptide-1 receptor agonists Complete Guide to GLP-1 Medications

This study evaluated the therapeutic potential of non-gene-edited human chemically induced pluripotent stem cell-derived neural stem cells (hCiPSC-NSCs) in a prenatal valproic acid (VPA)-induced rat model of ASD, using a dual-pathway administration strategy (intravenous systemic delivery combined with an intracerebroventricular boost)

[DOI] [PubMed] [Google Scholar] 97.Sindhu U., Sharma A., Zawar I., Punia V

Estimates of dosing rate and average steady-state concentrations, which may be calculated using clearance, are independent of any specific pharmacokinetic model

This is what makes the treatment work in 20 minutes instead of over weeks